Age-Related Neurodegeneration and Memory Loss in Down Syndrome
Author(s) -
Jason Lockrow,
Ashley M. Fortress,
AnnCharlotte Granholm
Publication year - 2012
Publication title -
current gerontology and geriatrics research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.564
H-Index - 28
eISSN - 1687-7071
pISSN - 1687-7063
DOI - 10.1155/2012/463909
Subject(s) - neuropathology , neurodegeneration , neuroscience , medicine , down syndrome , pathological , disease , memory impairment , trisomy , degeneration (medical) , oxidative stress , cognition , pathology , psychology , biology , psychiatry , genetics
Down syndrome (DS) is a condition where a complete or segmental chromosome 21 trisomy causes variable intellectual disability, and progressive memory loss and neurodegeneration with age. Many research groups have examined development of the brain in DS individuals, but studies on age-related changes should also be considered, with the increased lifespan observed in DS. DS leads to pathological hallmarks of Alzheimer's disease (AD) by 40 or 50 years of age. Progressive age-related memory deficits occurring in both AD and in DS have been connected to degeneration of several neuronal populations, but mechanisms are not fully elucidated. Inflammation and oxidative stress are early events in DS pathology, and focusing on these pathways may lead to development of successful intervention strategies for AD associated with DS. Here we discuss recent findings and potential treatment avenues regarding development of AD neuropathology and memory loss in DS.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom